APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal OTC Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032

Report ID 173994250220 December 2025197 pages

Choose your research edition.

Industry ResearchGastrointestinal OTC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal OTC Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastrointestinal OTC Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastrointestinal OTC Drugs include Boehringer Ingelheim, Perrigo, Procter & Gamble, Purdue Pharma, Reckitt Benckiser, Bayer, GlaxoSmithKline, Pfizer and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastrointestinal OTC Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastrointestinal OTC Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Gastrointestinal OTC Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal OTC Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastrointestinal OTC Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastrointestinal OTC Drugs sales, projected growth trends, production technology, application and end-user industry.

Gastrointestinal OTC Drugs Segment by Company

Boehringer Ingelheim

Perrigo

Procter & Gamble

Purdue Pharma

Reckitt Benckiser

Bayer

GlaxoSmithKline

Pfizer

Johnson & Johnson

Nestle

Sanofi

Teva Pharmaceutical

Abbott

Gastrointestinal OTC Drugs Segment by Type

Anti-Emetics

Laxatives

Anti-Flatulents

Anti-Diarrheals

PPIs

H2-Antaginists

Other

Gastrointestinal OTC Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Gastrointestinal OTC Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal OTC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal OTC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal OTC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastrointestinal OTC Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal OTC Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-Emetics Major Manufacturers Table 3. Laxatives Major Manufacturers Table 4. Anti-Flatulents Major Manufacturers Table 5. Anti-Diarrheals Major Manufacturers Table 6. PPIs Major Manufacturers Table 7. H2-Antaginists Major Manufacturers Table 8. Other Major Manufacturers Table 9. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Retail Pharmacies Major Manufacturers Table 11. Online Pharmacies Major Manufacturers Table 12. Hospital Pharmacies Major Manufacturers Table 13. Gastrointestinal OTC Drugs Industry Trends Table 14. Gastrointestinal OTC Drugs Industry Drivers Table 15. Gastrointestinal OTC Drugs Industry Opportunities and Challenges Table 16. Gastrointestinal OTC Drugs Industry Restraints Table 17. Global Gastrointestinal OTC Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gastrointestinal OTC Drugs Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Gastrointestinal OTC Drugs Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2026) Table 21. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2027-2032) Table 22. Global Gastrointestinal OTC Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (K Units) Table 24. Global Gastrointestinal OTC Drugs Sales by Region (2027-2032) & (K Units) Table 25. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2026) Table 26. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2027-2032) Table 27. Global Gastrointestinal OTC Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Gastrointestinal OTC Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2021-2026) Table 31. Global Gastrointestinal OTC Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Gastrointestinal OTC Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Gastrointestinal OTC Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Gastrointestinal OTC Drugs Manufacturers, Product Type & Application Table 35. Global Gastrointestinal OTC Drugs Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Gastrointestinal OTC Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Gastrointestinal OTC Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2026) Table 42. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2027-2032) Table 43. Global Gastrointestinal OTC Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 45. Global Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 46. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2026) Table 47. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2027-2032) Table 48. Global Gastrointestinal OTC Drugs Price by Type (2021-2026) & (US$/Unit) Table 49. Global Gastrointestinal OTC Drugs Price by Type (2027-2032) & (US$/Unit) Table 50. Global Gastrointestinal OTC Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2026) Table 54. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2027-2032) Table 55. Global Gastrointestinal OTC Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2026) Table 59. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2027-2032) Table 60. Global Gastrointestinal OTC Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Gastrointestinal OTC Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Perrigo Company Information Table 68. Perrigo Business Overview Table 69. Perrigo Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Perrigo Gastrointestinal OTC Drugs Product Portfolio Table 71. Perrigo Recent Development Table 72. Procter & Gamble Company Information Table 73. Procter & Gamble Business Overview Table 74. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio Table 76. Procter & Gamble Recent Development Table 77. Purdue Pharma Company Information Table 78. Purdue Pharma Business Overview Table 79. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio Table 81. Purdue Pharma Recent Development Table 82. Reckitt Benckiser Company Information Table 83. Reckitt Benckiser Business Overview Table 84. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio Table 86. Reckitt Benckiser Recent Development Table 87. Bayer Company Information Table 88. Bayer Business Overview Table 89. Bayer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bayer Gastrointestinal OTC Drugs Product Portfolio Table 91. Bayer Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer Gastrointestinal OTC Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. Johnson & Johnson Company Information Table 103. Johnson & Johnson Business Overview Table 104. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio Table 106. Johnson & Johnson Recent Development Table 107. Nestle Company Information Table 108. Nestle Business Overview Table 109. Nestle Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Nestle Gastrointestinal OTC Drugs Product Portfolio Table 111. Nestle Recent Development Table 112. Sanofi Company Information Table 113. Sanofi Business Overview Table 114. Sanofi Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sanofi Gastrointestinal OTC Drugs Product Portfolio Table 116. Sanofi Recent Development Table 117. Teva Pharmaceutical Company Information Table 118. Teva Pharmaceutical Business Overview Table 119. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio Table 121. Teva Pharmaceutical Recent Development Table 122. Abbott Company Information Table 123. Abbott Business Overview Table 124. Abbott Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Abbott Gastrointestinal OTC Drugs Product Portfolio Table 126. Abbott Recent Development Table 127. North America Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 130. North America Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 131. North America Gastrointestinal OTC Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 132. North America Gastrointestinal OTC Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 133. North America Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 136. North America Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 137. North America Gastrointestinal OTC Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 138. North America Gastrointestinal OTC Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 139. North America Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. North America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 144. North America Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 145. North America Gastrointestinal OTC Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 146. North America Gastrointestinal OTC Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 147. United States Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 148. Canada Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 149. Europe Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 152. Europe Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 153. Europe Gastrointestinal OTC Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Europe Gastrointestinal OTC Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Europe Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 158. Europe Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 159. Europe Gastrointestinal OTC Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Europe Gastrointestinal OTC Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Europe Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Europe Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 166. Europe Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 167. Europe Gastrointestinal OTC Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Europe Gastrointestinal OTC Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Germany Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 170. France Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 171. U.K. Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 172. Italy Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 174. Nordic Countries Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 175. China Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 176. China Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 177. China Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 178. China Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 179. China Gastrointestinal OTC Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 180. China Gastrointestinal OTC Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 181. China Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 182. China Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 183. China Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 184. China Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 185. China Gastrointestinal OTC Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 186. China Gastrointestinal OTC Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 190. Asia Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 191. Asia Gastrointestinal OTC Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 192. Asia Gastrointestinal OTC Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 193. Asia Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 196. Asia Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 197. Asia Gastrointestinal OTC Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 198. Asia Gastrointestinal OTC Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 199. Asia Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. Asia Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 204. Asia Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 205. Asia Gastrointestinal OTC Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 206. Asia Gastrointestinal OTC Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Japan Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 208. South Korea Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 209. India Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 210. Australia Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 211. China Taiwan Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 216. SAMEA Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 217. SAMEA Gastrointestinal OTC Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 218. SAMEA Gastrointestinal OTC Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 219. SAMEA Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 222. SAMEA Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 223. SAMEA Gastrointestinal OTC Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 224. SAMEA Gastrointestinal OTC Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 225. SAMEA Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 229. SAMEA Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 230. SAMEA Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 231. SAMEA Gastrointestinal OTC Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 232. SAMEA Gastrointestinal OTC Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 233. Brazil Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 234. Argentina Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 235. Chile Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 236. Colombia Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 237. Peru Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 239. Israel Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 240. UAE Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 241. Turkey Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 242. Iran Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 243. Egypt Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Gastrointestinal OTC Drugs Distributors List Table 247. Gastrointestinal OTC Drugs Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Gastrointestinal OTC Drugs Image Figure 2. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal OTC Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-Emetics Image Figure 5. Laxatives Image Figure 6. Anti-Flatulents Image Figure 7. Anti-Diarrheals Image Figure 8. PPIs Image Figure 9. H2-Antaginists Image Figure 10. Other Image Figure 11. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Gastrointestinal OTC Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 13. Retail Pharmacies Image Figure 14. Online Pharmacies Image Figure 15. Hospital Pharmacies Image Figure 16. Global Gastrointestinal OTC Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Figure 18. Global Gastrointestinal OTC Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Gastrointestinal OTC Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2032) Figure 21. Global Gastrointestinal OTC Drugs Sales (2021-2032) & (K Units) Figure 22. Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Gastrointestinal OTC Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Europe Gastrointestinal OTC Drugs Sales YoY (2021-2032) & (K Units) Figure 26. China Gastrointestinal OTC Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Gastrointestinal OTC Drugs Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales YoY (2021-2032) & (K Units) Figure 29. Global Gastrointestinal OTC Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Gastrointestinal OTC Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Gastrointestinal OTC Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Gastrointestinal OTC Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032) Figure 35. Global Gastrointestinal OTC Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Gastrointestinal OTC Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032) Figure 38. Global Gastrointestinal OTC Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Gastrointestinal OTC Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032) Figure 41. Global Gastrointestinal OTC Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Gastrointestinal OTC Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032) Figure 44. North America Gastrointestinal OTC Drugs Revenue Share by Type (2021-2032) Figure 45. North America Gastrointestinal OTC Drugs Sales Share by Type (2021-2032) Figure 46. North America Gastrointestinal OTC Drugs Revenue Share by Application (2021-2032) Figure 47. North America Gastrointestinal OTC Drugs Sales Share by Application (2021-2032) Figure 48. North America Gastrointestinal OTC Drugs Revenue Share by Country (2021-2032) Figure 49. North America Gastrointestinal OTC Drugs Sales Share by Country (2021-2032) Figure 50. Europe Gastrointestinal OTC Drugs Revenue Share by Type (2021-2032) Figure 51. Europe Gastrointestinal OTC Drugs Sales Share by Type (2021-2032) Figure 52. Europe Gastrointestinal OTC Drugs Revenue Share by Application (2021-2032) Figure 53. Europe Gastrointestinal OTC Drugs Sales Share by Application (2021-2032) Figure 54. Europe Gastrointestinal OTC Drugs Revenue Share by Country (2021-2032) Figure 55. Europe Gastrointestinal OTC Drugs Sales Share by Country (2021-2032) Figure 56. China Gastrointestinal OTC Drugs Revenue Share by Type (2021-2032) Figure 57. China Gastrointestinal OTC Drugs Sales Share by Type (2021-2032) Figure 58. China Gastrointestinal OTC Drugs Revenue Share by Application (2021-2032) Figure 59. China Gastrointestinal OTC Drugs Sales Share by Application (2021-2032) Figure 60. Asia Gastrointestinal OTC Drugs Revenue Share by Type (2021-2032) Figure 61. Asia Gastrointestinal OTC Drugs Sales Share by Type (2021-2032) Figure 62. Asia Gastrointestinal OTC Drugs Revenue Share by Application (2021-2032) Figure 63. Asia Gastrointestinal OTC Drugs Sales Share by Application (2021-2032) Figure 64. Asia Gastrointestinal OTC Drugs Revenue Share by Country (2021-2032) Figure 65. Asia Gastrointestinal OTC Drugs Sales Share by Country (2021-2032) Figure 66. SAMEA Gastrointestinal OTC Drugs Revenue Share by Type (2021-2032) Figure 67. SAMEA Gastrointestinal OTC Drugs Sales Share by Type (2021-2032) Figure 68. SAMEA Gastrointestinal OTC Drugs Revenue Share by Application (2021-2032) Figure 69. SAMEA Gastrointestinal OTC Drugs Sales Share by Application (2021-2032) Figure 70. SAMEA Gastrointestinal OTC Drugs Revenue Share by Country (2021-2032) Figure 71. SAMEA Gastrointestinal OTC Drugs Sales Share by Country (2021-2032) Figure 72. Gastrointestinal OTC Drugs Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Gastrointestinal OTC Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Emetics
  • Laxatives
  • Anti-Flatulents
  • Anti-Diarrheals
  • PPIs
  • H2-Antaginists
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Perrigo
  • Procter & Gamble
  • Purdue Pharma
  • Reckitt Benckiser
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Nestle
  • Sanofi
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastrointestinal OTC Drugs Market by Type
  3. 1.2.1 Global Gastrointestinal OTC Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-Emetics
  5. 1.2.3 Laxatives
  6. 1.2.4 Anti-Flatulents
  7. 1.2.5 Anti-Diarrheals
  8. 1.2.6 PPIs
  9. 1.2.7 H2-Antaginists
  10. 1.2.8 Other
  11. 1.3 Gastrointestinal OTC Drugs Market by Application
  12. 1.3.1 Global Gastrointestinal OTC Drugs Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Retail Pharmacies
  14. 1.3.3 Online Pharmacies
  15. 1.3.4 Hospital Pharmacies
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Gastrointestinal OTC Drugs Market Dynamics
  1. 2.1 Gastrointestinal OTC Drugs Industry Trends
  2. 2.2 Gastrointestinal OTC Drugs Industry Drivers
  3. 2.3 Gastrointestinal OTC Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal OTC Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastrointestinal OTC Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastrointestinal OTC Drugs Revenue by Region
  3. 3.2.1 Global Gastrointestinal OTC Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastrointestinal OTC Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastrointestinal OTC Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastrointestinal OTC Drugs Sales by Region
  9. 3.4.1 Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastrointestinal OTC Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Gastrointestinal OTC Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers
  2. 4.1.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastrointestinal OTC Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastrointestinal OTC Drugs Sales by Manufacturers
  6. 4.2.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastrointestinal OTC Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastrointestinal OTC Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastrointestinal OTC Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastrointestinal OTC Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastrointestinal OTC Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Gastrointestinal OTC Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastrointestinal OTC Drugs Market CR5 and HHI
  16. 4.8.2 2025 Gastrointestinal OTC Drugs Tier 1, Tier 2, and Tier 3
5 Gastrointestinal OTC Drugs Market by Type
  1. 5.1 Global Gastrointestinal OTC Drugs Revenue by Type
  2. 5.1.1 Global Gastrointestinal OTC Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastrointestinal OTC Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastrointestinal OTC Drugs Sales by Type
  6. 5.2.1 Global Gastrointestinal OTC Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal OTC Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastrointestinal OTC Drugs Price by Type
6 Gastrointestinal OTC Drugs Market by Application
  1. 6.1 Global Gastrointestinal OTC Drugs Revenue by Application
  2. 6.1.1 Global Gastrointestinal OTC Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastrointestinal OTC Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastrointestinal OTC Drugs Sales by Application
  6. 6.2.1 Global Gastrointestinal OTC Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastrointestinal OTC Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastrointestinal OTC Drugs Price by Application
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Perrigo
  8. 7.2.1 Perrigo Company Information
  9. 7.2.2 Perrigo Business Overview
  10. 7.2.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
  12. 7.2.5 Perrigo Recent Developments
  13. 7.3 Procter & Gamble
  14. 7.3.1 Procter & Gamble Company Information
  15. 7.3.2 Procter & Gamble Business Overview
  16. 7.3.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
  18. 7.3.5 Procter & Gamble Recent Developments
  19. 7.4 Purdue Pharma
  20. 7.4.1 Purdue Pharma Company Information
  21. 7.4.2 Purdue Pharma Business Overview
  22. 7.4.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
  24. 7.4.5 Purdue Pharma Recent Developments
  25. 7.5 Reckitt Benckiser
  26. 7.5.1 Reckitt Benckiser Company Information
  27. 7.5.2 Reckitt Benckiser Business Overview
  28. 7.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
  30. 7.5.5 Reckitt Benckiser Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Johnson & Johnson
  50. 7.9.1 Johnson & Johnson Company Information
  51. 7.9.2 Johnson & Johnson Business Overview
  52. 7.9.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
  54. 7.9.5 Johnson & Johnson Recent Developments
  55. 7.10 Nestle
  56. 7.10.1 Nestle Company Information
  57. 7.10.2 Nestle Business Overview
  58. 7.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
  60. 7.10.5 Nestle Recent Developments
  61. 7.11 Sanofi
  62. 7.11.1 Sanofi Company Information
  63. 7.11.2 Sanofi Business Overview
  64. 7.11.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
  66. 7.11.5 Sanofi Recent Developments
  67. 7.12 Teva Pharmaceutical
  68. 7.12.1 Teva Pharmaceutical Company Information
  69. 7.12.2 Teva Pharmaceutical Business Overview
  70. 7.12.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
  72. 7.12.5 Teva Pharmaceutical Recent Developments
  73. 7.13 Abbott
  74. 7.13.1 Abbott Company Information
  75. 7.13.2 Abbott Business Overview
  76. 7.13.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
  78. 7.13.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Gastrointestinal OTC Drugs Market Size by Type
  2. 8.1.1 North America Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Gastrointestinal OTC Drugs Price by Type (2021-2032)
  5. 8.2 North America Gastrointestinal OTC Drugs Market Size by Application
  6. 8.2.1 North America Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Gastrointestinal OTC Drugs Price by Application (2021-2032)
  9. 8.3 North America Gastrointestinal OTC Drugs Market Size by Country
  10. 8.3.1 North America Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastrointestinal OTC Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gastrointestinal OTC Drugs Market Size by Type
  2. 9.1.1 Europe Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastrointestinal OTC Drugs Price by Type (2021-2032)
  5. 9.2 Europe Gastrointestinal OTC Drugs Market Size by Application
  6. 9.2.1 Europe Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastrointestinal OTC Drugs Price by Application (2021-2032)
  9. 9.3 Europe Gastrointestinal OTC Drugs Market Size by Country
  10. 9.3.1 Europe Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastrointestinal OTC Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Gastrointestinal OTC Drugs Market Size by Type
  2. 10.1.1 China Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Gastrointestinal OTC Drugs Price by Type (2021-2032)
  5. 10.2 China Gastrointestinal OTC Drugs Market Size by Application
  6. 10.2.1 China Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Gastrointestinal OTC Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastrointestinal OTC Drugs Market Size by Type
  2. 11.1.1 Asia Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastrointestinal OTC Drugs Price by Type (2021-2032)
  5. 11.2 Asia Gastrointestinal OTC Drugs Market Size by Application
  6. 11.2.1 Asia Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastrointestinal OTC Drugs Price by Application (2021-2032)
  9. 11.3 Asia Gastrointestinal OTC Drugs Market Size by Country
  10. 11.3.1 Asia Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastrointestinal OTC Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastrointestinal OTC Drugs Market Size by Type
  2. 12.1.1 SAMEA Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastrointestinal OTC Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Gastrointestinal OTC Drugs Market Size by Application
  6. 12.2.1 SAMEA Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastrointestinal OTC Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Gastrointestinal OTC Drugs Market Size by Country
  10. 12.3.1 SAMEA Gastrointestinal OTC Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastrointestinal OTC Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastrointestinal OTC Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastrointestinal OTC Drugs Value Chain Analysis
  2. 13.1.1 Gastrointestinal OTC Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastrointestinal OTC Drugs Production Mode & Process
  6. 13.2 Gastrointestinal OTC Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastrointestinal OTC Drugs Distributors
  9. 13.2.3 Gastrointestinal OTC Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst